Pencil Biosciences is pioneering the next generation of gene editing. We are developing a fully synthetic, RNA-guided platform designed to overcome the limitations of current technologies.

Our modular system is small, flexible, and non-CRISPR in nature —reducing immunogenicity risk and expanding what’s possible in therapeutics and cell line engineering.